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61664 | RSC Adv., 2015, 5, 61664–6167e synthesis of fused oxazolidines
and highly substituted 1H-pyrrolo [2,1-c][1,4]
oxazines via C–H functionalization†
Chottanahalli. S. Pavan Kumar, Kachigere. B. Harsha, Kempegowda Mantelingu*
and Kanchugarakoppal. S. Rangappa*
The ﬁrst one pot protocol for the diastereoselective synthesis of oxazolo[2,3-c]isoquinoline was achieved
by a metal-free, benzoic acid catalyzed reaction of 1,2,3,4-tetrahydroisoquinoline or trypoline with
aldehydes under mild conditions via C–H, C–O bond functionalization. A new approach for the synthesis
of highly substituted 1H-pyrrolo[2,1-c][1,4]oxazine was carried out.Functionalization of C–H bonds into C–C and/or C–O bonds is
an important area of organic synthesis for the construction of
biologically active complex molecules.1 [3 + 2]-Cycloadditions of
azomethine ylides are the powerful tools to construct hetero-
cyclic compounds from relatively simple precursors.2 Many
methods are available to generate nonstabilized azomethine
ylides in situ, these dipolar species are most frequently prepared
via decarboxylative condensation of aldehydes with amino acids
such as proline and sarcosine.3 Examples of azomethine ylide
formation from simple, unfunctionalized cyclic amines and
their subsequent dipolar cycloadditions remain rare as they
require relatively high reaction temperatures even for the most
activated amines such as 1,2,3,4-tetrahydroisoquinoline
(THIQ). The domino reaction is one of the major strategies for
the construction of novel heterocycles from easily available
starting materials.4 However, the utilities of redox-neutral
domino reactions in stereo selective syntheses of bioactive
molecules have not been extensively explored so far. Tetrahy-
drooxazolidines and pyrrolo[2,1-c][1,4]oxazine are the key
intermediates in synthetic as well as in pharmaceutical chem-
istry and are important building blocks in the syntheses of
various biologically active nitrogen containing heterocycles.5,6
As a consequence, substantial attention has been paid to
develop eﬃcient methods for their syntheses.7,8 Very recently,
Hajra and co-workers9 accomplished the diastereoselective
synthesis of fused oxazolidines by aromatic aldehydes and
pyrrolidine, using potassium acetate under microwave condi-
tions but substrate scope was limited.anasagangotri, Mysuru-06, India. E-mail:
(ESI) available: CCDC 3j-1061480,
and 7a-1061479. For ESI and
ther electronic format see DOI:
0In continuation of our interest in in situ generated azome-
thine ylide followed by the intermolecular [3 + 2]-cycloaddition
reaction10 and synthesis of heterocyclic compounds11 we
explored a method to access intermolecular [3 + 2]-
cycloadditions of azomethine ylides from simple THIQs and
trypolines under mild conditions. To facilitate reaction devel-
opment, we began our investigation with THIQ (1.0 equiv.) and
2-bromobenzaldehyde (2.0 equiv.) under reux for 18 h in
toluene. The expected product was formed in 36% yield (Table
1, entry 1) as a single diastereomer in which two phenyl groups
are in trans arrangement and the structure of this diastereomer
was conrmed by single X-ray crystal studies. As it has been
shown that benzoic acid and molecular sieves facilitate amine
a-functionalization via intermediate azomethine ylides,12 we
tested benzoic acid as an additive at 20 mol% loading which led
to marked rate acceleration with the reaction being completed
aer 4 h (Table 1, entry 2) giving an increased yield of 45%
(Table 1, entry 2). The mild acids like acetic acid and 2-ethyl
hexanoic acid were quite less eﬀective (Table 1, entries 17–18)
and strong acids such as CF3COOH and p-toluene sulfonoic acid
were ineﬀective. The solvents screened included CH3CN, THF,
EtOAc, xylene, DMF and toluene among which CH3CN was
found to be the prefered solvent (Table 1, entries 9–13). A lower
amount of the desired product was obtained at room temper-
ature when it was stirred for 48 h (Table 1, entry 8). Remarkably,
the reaction proceeded eﬃciently at 50 C. In fact, the highest
yield of 3j (78%) was realized at this instance (Table 1, entry 9).
No signicant change in the yield was observed when benzoic
acid was increased to 50 mol% (Table 1, entry 14). Reduction in
the loading of benzoic acid to 10 mol% had negative eﬀect on
the yield of 3j (Table 1, entry 15). The optimized reaction
condition was 20mol% benzoic acid in CH3CN at 50 C (Table 1,
entry 9).
Having identied a useful set of reaction conditions,
remarkable tolerance toward electronic demands ofThis journal is © The Royal Society of Chemistry 2015
Table 1 Reaction optimization for 3ja
Entry Additives (mol%) Solvents T [C] Time [h] Yieldb (%)
1 — Toluene Reux 18 36
2 PhCO2H(20) Toluene Reux 4 45
3 PhCO2H(20) Toluene 100 5 48
4 PhCO2H(20) Toluene 80 7 51
5 PhCO2H(20) Toluene 60 18 62
6 PhCO2H(20) Toluene 50 18 65
7 PhCO2H(20) Toluene 40 24 58
8 PhCO2H(20) Toluene rt 48 59
9 PhCO2H(20) CH3CN 50 14 78
10 PhCO2H(20) Benzene 50 24 57
11 PhCO2H(20) Xylene 40 24 63
12 PhCO2H(20) EtOAc 50 24 NR
13 PhCO2H(20) THF 50 24 NR
14 PhCO2H(50) CH3CN 50 12 74
15 PhCO2H(10) CH3CN 50 12 57
16 CH3CO2H(20) CH3CN 50 24 61
17 EHA(20) CH3CN 50 24 63
18 CF3CO2H(20) CH3CN 50 24 NR
19 PTSA(20) CH3CN 50 24 NR
a Reactions were performed with 1.0 mmol of 2 and 1.2 mmol of THIQ
1a. b Yields are of chromatographically isolated puried compounds.
Scheme 1 Examples of the redox-neutral approach.


































View Article Onlinesubstituent's in the aldehyde precursors was shown (Scheme 2).
The presence of electron-donating groups like –Me, tert-butyl
and even N(Me)2 delivered oxazolidine analogues in moderate
yields (3b–d). Aldehydes bearing halogens such as –F, –Cl, –Br,
CF3 and a strong electron-withdrawing group like –NO2 were
underwent the title reaction to form desired products in good
yields (3f–j). Even disubstituted aldehyde successfully formed
the product without diminishing the yield 3k. Piperonal and
Hetero cyclic aldehyde like 2-thiophene carboxaldehyde also
underwent the reaction to give the desired product 3e and 3l
respectively in good yields. Moreover in each case, the forma-
tion of a single diastereomer was observed and the absolute
stereochemistry was unambiguously determined by single X-ray
crystallography for the compounds (3j, 3k and 3o). The scope of
the reaction was successfully extended to other substrates such
as trypoline and sterically demanding 1-alkyl THIQ, 1-aryl THIQ
and 1-aryl-trypoline which also underwent the title reaction
under equally mild conditions (3m–r).
The other high reactive amines like isoindoline failed to give
the desired product but under similar reaction condition it ends
up with an unusual product 5b (Scheme 3) which was nally
conrmed by single X-ray crystal studies.
With the interest of further enhancement of scope of the
process the reaction was performed with challenging precursor
like pyrrolidine. Examples of azomethine ylide formation from
simple, unfunctionalized cyclic amines like pyrrolidine remainThis journal is © The Royal Society of Chemistry 2015rare as they require relatively high reaction temperatures.10,12
The reaction up to difuctionalization and aromatization was
reported under harsh and microwave condition (Scheme 1).13 In
this context, we were particularly delighted to discover a rare
poly C–H bond functionalization via domino process which
furnished the highly substituted 1H-pyrrolo[2,1-c][1,4]oxazines.RSC Adv., 2015, 5, 61664–61670 | 61665
Scheme 3 Unusual product with isoindoline.


































View Article OnlineWe were surprised with the formation of 1H-pyrrolo[2,1-c][1,4]
oxazine derivative as a major product with the yield of 40% with
only 2 equivalence of aldehyde. Then with intent of increasing
the yield of the product, the reaction was successfully carried
out with 4 equivalence of aldehyde to yield upto 65% while the 5
equivalence of aldehyde had no further positive impact on the
yield of the product. The structure of the compound 7a was
conrmed by single X-ray crystal (Fig 1).
There are very few methods available for the synthesis of
substituted pyrrolo benzoxazines and oxazines which suﬀer
from demerits like high cost, multistep and tedious process.8
To the best of our knowledge, this methodology represents
the rst one pot protocol for the synthesis of highly substituted
fused 1H-pyrrolo[2,1-c][1,4]oxazine derivatives from readily
available cost eﬀective precursors (Scheme 4).
A probable mechanistic explanation for the formation of
fused oxazolo[2,3-a]isoquinoline reaction is outlined in Scheme
5. The rst step is the formation of the iminium ion C by the
reaction between THIQ and aldehyde. Then iminium ion CFig. 1 ORTEP crystal structure of 3k and 7a.
Scheme 4 Synthesis of 1H-pyrrolo[2,1-c][1,4]oxazines.
61666 | RSC Adv., 2015, 5, 61664–61670transformed into azomethine ylide D via iminium a-deproto-
nation by the carboxylate anion.5a The intermolecular [3 + 2]-
cycloaddition reaction between another equivalent of the alde-
hyde and the generated azomethine ylide D aﬀorded the cor-
responding product 3a in good yield.
Conclusion
In summary, we present a simple and versatile method for the
diastereoselective synthesis of fused oxazolidine derivatives and
1H-pyrrolo[2,1-c][1,4]oxazine via amine C–H and aldehyde C–O
bond funtionalization for the rst time. All of the synthesized
oxazolidine derivatives obtained as a single diastereomer. The
less reactive substrate like pyrrolidine underwent redox neutral
domino reaction to give highly substituted 1H-pyrrolo[2,1-c][1,4]
oxazine derivatives. Eﬃcient, One pot, mild, transition metal-
free conditions, cost eﬀective, readily accessible precursors
and broad substrate scope are the attractive features of this
protocol. The excellent levels in terms of constructing fused ve
membered and six membered hetero cycles suggest this strategy
as a valuable candidate for the preparation of stereo chemically
dened oxazolidine derivatives and highly substituted 1H-pyr-





Colorless solid; yield 68%; (Rf ¼ 0.8 in hexanes/EtOAc 95 : 05
v/v); MP 142–144 C; IR (KBr): 3010, 2850, 1670, 1639, 1608, 1070
cm1; 1H NMR (400 MHz, CDCl3): d 7.42 (dd, J ¼ 1.6 Hz, 8.8 Hz,
1H), 7.27–7.23 (comp, 3H), 7.21–7.12 (comp, 9H), 7.11–7.08 (m,
1H), 5.72 (s, 1H), 4.77 (d, J¼ 8.0 Hz, 1H), 3.90 (d, J¼ 6.8 Hz, 1H),
3.06–2.97 (m, 2H), 2.85–2.82 (m, 1H), 2.76–2.71 (m, 1H); 13C
NMR (100 MHz, CDCl3): d ¼ 140.5, 139.6, 135.6, 133.3, 128.8,
128.5, 128.3, 127.7, 127.46, 127.43, 126.9, 126.65, 126.60, 90.4,




Colorless solid; yield 64%; (Rf ¼ 0.86 in hexanes/EtOAc 80 : 20
v/v); MP 138–140 C; IR (KBr): 3018, 2915, 1670, 1629, 1599, 1050

































View Article Online7.32–7.26 (m, 2H), 7.22–7.17 (comp, 2H), 7.15–7.10 (m, 5H), 7.06
(d, J ¼ 5.2 Hz, 2H), 5.78 (s, 1H), 4.81 (d, J ¼ 7.6 Hz, 1H), 3.92 (d,
J ¼ 7.2 Hz, 1H), 3.13–3.05 (m, 2H), 3.02–2.80 (m, 2H), 2.34 (s,
3H), 2.30 (s, 3H); 13C NMR (100 MHz, CDCl3): d ¼ 137.5, 137.4,
136.9, 136.6, 135.6, 133.5, 129.1, 129.0, 128.6, 127.9, 127.0,
126.7, 126.4, 126.1, 90.2, 87.2, 75.9, 46.5, 28.3, 21.0;m/z (ESI-MS)
[M + H]+ calculated 356.1936 found 356.1956.
()-3c:(2S,3S,10bR)-2,3-Bis(4-tert-butylphenyl)-
3,5,6,10btetrahydro-2H-oxazolo[2,3-a]isoquinoline
Colorless solid; yield 70%; (Rf ¼ 0.88 in hexanes/EtOAc 80 : 20
v/v); MP 148–150 C; IR (KBr): 3018, 2902, 2898, 2853, 1673,
1648, 1621, 1070 cm1; 1H NMR (400 MHz, CDCl3): d ¼ 7.50–
7.48 (m, 1H), 7.39–7.33 (m, 2H), 7.13 (d, J ¼ 7.2 Hz, 4H), 7.28–
7.23 (m, 4H), 7.20–7.16 (m, 1H), 5.76 (s, 1H), 4.86 (d, J ¼ 7.6 Hz,
1H), 4.02 (d, J ¼ 7.2 Hz, 1H), 3.22–3.17 (m, 1H), 3.09–2.95 (m,
2H), 2.87–2.80 (m, 1H), 1.32 (s, 9H), 1.29 (s, 9H); 13C NMR (100
MHz, CDCl3): d ¼ 150.6, 150.0, 138.3, 138.0, 136.8, 135.6, 133.2,
128.8, 127.9, 126.5, 126.3, 126.0, 125.4, 125.3, 90.3, 86.8, 75.8,




Colorless solid yield 60%; (Rf ¼ 0.65 in hexanes/EtOAc 80 : 20
v/v); MP 124–126 C; IR (KBr): 3018, 2850, 1640, 1639, 1622, 1079
cm1; 1H NMR (400 MHz, CDCl3): d ¼ 7.51 (d, J ¼ 8.0 Hz, 1H),
7.26–7.13 (comp, 6H), 7.07–7.05 (m, 2H), 6.79 (t, J¼ 6.8 Hz, 2H),
4.92 (s, 1H), 4.62 (d, J¼ 8.4 Hz, 1H), 3.88 (d, J¼ 8.0 Hz, 1H), 2.99
(s, 12H), 2.94–2.89 (m, 2H), 2.58–2.55 (m, 2H); 13C NMR (100
MHz, CDCl3): d ¼ 135.1, 130.0, 128.8, 128.5, 128.1, 127.8, 126.8,
126.3, 125.6, 125.0, 112.1, 90.3, 85.1, 70.07, 45.7, 41.8, 29.4; m/z
(ESI-MS) [M + H]+ calculated 401.2389 found 401.2381.
()-3e:(2S,3S,10bR)-2,3-Di(benzo[d][1,3]dioxol-5-yl)-
3,5,6,10btetrahydro-2H-oxazolo[2,3-a]isoquinoline
Colorless solid; yield 60%; (Rf ¼ 0.55 in hexanes/EtOAc 85 : 15
v/v); MP 114–116 C; IR (KBr): 3015, 2915, 1668, 1629, 1622, 107
cm1; 1H NMR (400 MHz, CDCl3): d ¼ 7.49 (t, J ¼ 4.0 Hz, 1H),
7.35–7.29 (m, 2H), 7.25 (d, J¼ 8 Hz, 6H), 7.22–7.18 (m, 1H), 7.16
(d, J ¼ 8 Hz, 1H), 5.8 (s, 1H), 4.76 (d, J ¼ 7.6 Hz, 1H), 3.87 (d, J ¼
7.2 Hz, 1H), 3.10–3.04 (m, 2H), 2.93–2.81 (m, 2H); 13C NMR (100
MHz, CDCl3): d ¼ 147.9, 147.7, 147.2, 146.9, 135.4, 134.1, 133.5,
133.1, 128.6, 128.5, 128.2, 126.5, 122.1, 120.4, 109.4, 108.1,
107.3, 106.6, 101.0, 100.9, 90.0, 87.3, 75.6, 46.3, 29.0; m/z (ESI-
MS) [M + H]+ calculated 402.1263 found 402.1259.
()-3f:(2S,3S,10bR)-2,3-Bis(4-chlorophenyl)-3,5,6,10b-
tetrahydro-2H-oxazolo[2,3-a]isoquinoline
Colorless solid; yield 80%; (Rf ¼ 0.55 in hexanes/EtOAc 95 : 05
v/v); MP 140–142 C; IR (KBr): 3012, 2852, 1667, 1648, 1633,
1079, 790 cm1; 1H NMR (400 MHz, CDCl3): d ¼ 7.28–7.23 (m,
2H), 7.19–7.16 (m, 2H), 7.09 (s, 1H), 6.92 (s, 1H), 6.82–6.71
(comp, 3H); 6.68 (d, J ¼ 3.2 Hz, 1H), 5.94 (s, 4H), 5.76 (s, 1H),
4.71 (d, J ¼ 7.6 Hz, 1H), 3.82 (d, J ¼ 7.6 Hz, 1H), 3.08 (t, J ¼ 6.0,This journal is © The Royal Society of Chemistry 20151H), 2.89–2.84 (m, 2H), 2.74–2.73 (m, 1H); 13C NMR (100 MHz,
CDCl3): d¼ 138.4, 137.7, 135.4, 133.7, 133.3, 133.2, 128.9, 128.7,
128.6, 128.4, 128.1, 128.0, 127.4, 126.6, 90.4, 86.6, 75.6, 46.4,
28.0;m/z (ESI-MS) [M + H]+ calculated 396.0844 found 396.0846.
()-3g:(2S,3S,10bR)-2,3-Bis(4-uorophenyl)-3,5,6,10b-
tetrahydro-2H-oxazolo[2,3-a]isoquinoline
Colorless solid; yield 65%; (Rf ¼ 0.50 in hexanes/EtOAc 95 : 05
v/v); MP 132–134 C; IR (KBr): 3012, 2895, 1680, 1619, 1611, 1110
cm1; 1H NMR (400 MHz, CDCl3): d ¼ 7.22 (dd, J ¼ 0.8 Hz, 8.8
Hz, 2H), 7.22–7.18 (m, 4H), 7.12–6.98 (m, 3H), 6.95–6.86 (m,
4H), 5.73 (s, 1H), 4.65 (d, J¼ 7.6 Hz, 1H), 3.80 (d, J¼ 7.6 Hz, 1H),
3.02–2.99 (m, 2H), 2.82–2.73 (m, 2H); 13C NMR (100 MHz,
CDCl3): d ¼ 163.6 (d, JC-F ¼ 72.8 Hz, 1C), 161.1 (d, JC-F ¼ 469.6
Hz, 1C), 135.5, 135.4, 134.8, 133.3, 128.8, 128.4, 128.4, 128.1,
128.09, 128.02, 115.6, 115.5, 115.38, 115.31, 90.3, 86.9, 75.5,




Colorless solid; yield 83%; (Rf ¼ 0.68 in hexanes/EtOAc 90 : 10
v/v); MP 100–102 C; IR (KBr): 3018, 2912, 1671, 1629, 1611,
1070, 990, 1118 cm1; 1H NMR (400 MHz, CDCl3): d¼ 7.62 (d, J¼
8.0 Hz, 2H), 7.56 (d, J¼ 8.1 Hz, 2H), 7.51 (d, J¼ 4.4 Hz, 1H), 7.46
(d, J¼ 8.4 Hz, 2H), 7.37–7.31 (m, 4H), 7.24–7.21 (m, 1H), 5.84 (s,
1H), 4.87 (d, J¼ 7.2 Hz, 1H), 3.0 (d, J¼ 7.0 Hz, 1H), 3.12–3.09 (m,
2H), 3.00–2.92 (m, 1H), 2.88–2.83 (m, 1H); 13C NMR (100 MHz,
CDCl3): d¼ 144.0, 143.2, 135.3, 132.7, 130.4, 130.1, 128.5, 128.3,
128.1, 127.4, 126.9, 126.6, 126.2, 125.6, 125.5, 125.3, 122.7,
122.6, 90.7, 86.3, 76.0, 46.6, 28.1; m/z (ESI-MS) [M + H]+ calcu-
lated 464.1371 found 464.1381.
()3i:(3S,10bR)-2,3-Bis(4-nitrophenyl)-3,5,6,10b-tetrahydro-
2Hoxazolo[2,3-a]isoquinoline
Colorless solid; yield 82%; (Rf ¼ 0.58 in hexanes/EtOAc 85 : 15
v/v); MP 136–138 C; IR (KBr): 3012, 2912, 1684, 1643, 1611,
1530, 1311, 1180 cm1; 1H NMR (400 MHz, CDCl3): d ¼ 8.22 (d,
J ¼ 8.4 Hz, 2H), 8.16 (d, J ¼ 8.4 Hz, 2H), 7.50 (t, J ¼ 7.6 Hz, 3H),
7.41 (d, J ¼ 8.20 Hz, 2H), 7.33 (t, J ¼ 4.4 Hz, 2H), 7.24–7.22 (m,
1H), 5.84 (s, 1H), 4.89 (d, J¼ 7.6 Hz, 1H), 4.04 (d, J¼ 6.8 Hz, 1H),
3.12–3.08 (m, 2H), 3.00–2.84 (m, 2H); 13C NMR (100 MHz,
CDCl3): d¼ 147.8, 147.7, 147.2, 146.3, 135.2, 132.3, 128.5, 128.4,
128.1, 127.90, 127.92, 127.4, 126.8, 124.0, 123.9, 91.0, 85.8, 76.0,




Colorless solid; yield 78%; (Rf ¼ 0.85 in hexanes/EtOAc 95 : 05
v/v); MP 138–140 C; IR (KBr) cm1 3014, 2910, 1658, 1612, 1112,
710, 738; 1H NMR (400 MHz, CDCl3): d¼ 7.83 (d, J¼ 7.2 Hz, 1H),
7.55–7.51 (m, 3H), 7.44 (d, J ¼ 8 Hz, 1H), 7.39 (t, J ¼ 7.6 Hz, 1H),
7.33–7.28 (m, 2H), 7.26–7.18 (m, 2H), 7.14 (t, J ¼ 7.6 Hz, 1H),

































View Article Online(d, J ¼ 6.4 Hz, 1H), 3.19–3.07 (m, 1H), 2.91–2.87 (m, 1H), 2.83 (t,
J ¼ 3.2 Hz, 1H), 2.79 (t, J ¼ 3.6 Hz, 1H); 13C NMR (100 MHz,
CDCl3): d ¼ 139.5, 135.4, 132.96, 132.90, 132.5, 129.0, 128.9,
128.8, 128.6, 128.4, 128.1, 128.0, 127.7, 127.6, 126.5, 124.8,
122.8, 90.5, 83.5, 74.9, 46.9, 28.6; m/z (ESI-MS) [M + H]+ calcu-
lated 472.9735 found 472.9727.
()-3k:(2S,3S,10bR)-2,3-Bis(5-bromo-2-methoxyphenyl)-
3,5,6,10btetrahydro-2H-oxazolo[2,3-a]isoquinoline
Colorless solid; yield 69%; (Rf ¼ 0.66 in hexanes/EtOAc 80 : 20
v/v); MP 134–136 C; IR (KBr): 3018, 2902, 1658, 1659, 1090, 690
cm1; 1H NMR (400 MHz, CDCl3): d¼ 7.79 (d, J¼ 2 Hz, 1H), 7.56
(d, J ¼ 2.4 Hz, 1H), 7.48–7.46 (m, 1H), 7.33–7.25 (m, 4H), 7.21–
7.19 (m, 1H), 6.66 (d, J¼ 8.4 Hz, 2H), 5.66 (s, 1H), 5.15 (d, J¼ 6.8
Hz, 1H), 4.36 (d, J ¼ 7.2 Hz, 1H), 3.53 (s, 3H), 3.44 (s, 3H), 3.22–
3.19 (m, 1H), 3.05–3.02 (m, 2H), 2.84–2.80 (m, 1H); 13C NMR
(100 MHz, CDCl3): d ¼ 156.3, 156.2, 135.7, 132.3, 131.0, 130.6,
130.3, 130.2, 130.1, 128.9, 128.2, 128.0, 126.3, 112.99, 112.97,
111.8, 111.6, 90.1, 79.2, 70.5, 55.3, 54.9, 47.4, 29.6; m/z (ESI-MS)
[M + H]+ calculated 546.0024 found 546.0018.
()-3l:(2R,3R,10bR)-2,3-Di(thiophen-2-yl)-3,5,6,10b-
tetrahydro-2Hoxazolo[2,3-a]isoquinoline
Yellow solid; yield 63%; (Rf¼ 0.75 in hexanes/EtOAc 80 : 20 v/v);
MP 120–122 C; IR (KBr): 3014, 2912, 1668, 1638, 1612, 1080
cm1; 1H NMR (400 MHz, CDCl3): d ¼ 7.37 (d, J ¼ 8.8 Hz, 1H),
7.21–7.13 (m, 4H), 7.12–7.08 (m, 1H), 6.95 (d, J ¼ 3.2 Hz, 1H),
6.90 (m, 1H), 6.85 (t, J ¼ 4.8 Hz, 2H), 5.66 (s, 1H), 5.14 (d, J ¼ 6.8
Hz, 1H), 4.30 (d, J ¼ 6.4 Hz, 1H), 3.20–3.13 (m, 1H), 3.08–3.03
(m, 1H), 2.95–2.87 (m, 1H), 2.78–2.72 (m, 1H); 13C NMR (100
MHz, CDCl3): d ¼ 142.8, 135.5, 132.4, 128.9, 128.7, 128.1, 127.9,
127.3, 126.3, 125.7, 125.4, 124.6, 124.0, 123.9, 90.3, 83.0, 72.9,





Colorless solid; yield 71%; (Rf ¼ 0.40 in hexanes/EtOAc 90 : 10
v/v); MP 162–164 C; IR (KBr): 3021, 2918, 1670, 1648, 1621,
1070, 658, 748 cm1; 1H NMR (400 MHz, CDCl3): d ¼ 7.52–7.50
(m, 2H), 7.46–7.41 (m, 3H), 7.35–7.29 (m, 5H), 7.11 (d, J ¼ 8.0
Hz, 2H), 6.90 (d, J ¼ 6.4, 11.2 Hz, 1H), 6.82 (d, J ¼ 8.4 Hz, 2H),
6.66 (d, J ¼ 2.8 Hz, 1H), 4.99 (d, J ¼ 8.8 Hz, 1H), 3.84 (dd, J ¼ 8.1
Hz, 1H), 3.84 (s, 3H), 3.15–3.09 (m, 1H), 2.87–2.78 (m, 2H), 2.59–
2.53 (m, 1H); 13C NMR (100 MHz, CDCl3): d ¼ 158.7, 146.0,
137.7, 136.3, 135.3, 131.7, 131.2, 130.4, 130.3, 130.2, 129.8,
129.0, 128.3, 127.8, 127.7, 121.9, 121.8, 113.3, 112.2, 112.1, 96.1,




Colorless solid; yield 45%; (Rf ¼ 0.40 in hexanes/EtOAc 80 : 20
v/v); MP 104–106 C; IR (KBr): 3394, 2998, 2934, 1685, 1604, 105461668 | RSC Adv., 2015, 5, 61664–61670cm1; 1H NMR (400 MHz, CDCl3): d ¼ 7.24–7.14 (m, 6H), 7.11–
7.08 (m, 1H), 7.05 (d, J ¼ 8.4 Hz, 1H), 6.96 (s, 1H), 6.84 (s, 1H),
4.85 (d, J ¼ 12.4 Hz, 1H), 3.9 (d, J ¼ 12, 1H), 3.84 (s, 3H), 3.76 (s,
3H), 3.05–3.0 (m, 2H), 2.94–2.84 (m, 2H), 1.07 (s, 3H); 13C NMR
(100 MHz, CDCl3): d ¼ 139.6, 138.8, 136.4, 135.7, 134.4, 134.2,
127.9, 127.7, 127.6, 127.4, 127.1, 127.0, 126.4, 125.6, 90.4, 86.6,
75.6, 55.3, 46.9, 28.5, 21.2; m/z (ESI-MS) [M + H]+ calculated
467.1420 found 468.1413.()-3o:2,3-Diphenyl-2,3,4,5,10,10b-hexahydro-1-oxa-3a,10-
diazacyclopenta[a]uorine
Colorless solid; yield 65%; (Rf ¼ 0.36 in hexanes/EtOAc
80 : 20 v/v); MP 144–146 C; IR (KBr): 3358, 3018, 2912,
1660, 1638, 1621, 1078 cm1; 1H NMR (400 MHz, CDCl3): d ¼
8.53 (s, 1H), 7.58 (d, J ¼ 7.6 Hz, 1H), 7.38–7.28 (m, 7H), 7.25–
7.14 (m, 6H), 7.12–7.09 (m, 1H), 7.01 (dd, J ¼ 2.0 Hz, 8 Hz,
1H), 6.22 (s, 1H), 5.01 (d, J ¼ 7.6 Hz, 1H), 4.02 (d, J ¼ 8.2 Hz,
1H), 3.24 (q, J ¼ 4.4 Hz, 2H) 2.88–2.86 (m, 1H), 2.68–2.64 (m,
1H); 13C NMR (100 MHz, CDCl3): d ¼ 138.8, 137.9, 136.6,
131.9, 128.6, 128.3, 128.0, 127.9, 127.2, 127.1, 126.8, 126.6,
126.59, 126.54, 122.5, 119.6, 119.5, 118.9, 111.4, 109.8, 88.5,
86.8, 71.4, 43.9, 29.7; m/z (ESI-MS) [M + H]+ calculated
367.1732 found 367.1748.()-3p: 2,3-Bis-(4-nitro-phenyl)-2,3,4,5,10,10b-hexahydro-1-
oxa-3a,10-diaza-cyclopenta[a]uorine
Colorless solid; yield 73%; (Rf ¼ 0.36 in hexanes/EtOAc 80 : 20
v/v); MP 154–156 C; IR (KBr): 3348, 3010, 2914, 1674, 1645,
1621, 1514, 1318, 1079 cm1; 1H NMR (400 MHz, CDCl3): d ¼
8.36 (br, s, 1H), 8.22 (d, J ¼ 8.8 Hz, 2H), 8.03 (d, J ¼ 8.4 Hz, 2H),
7.55 (d, J ¼ 8.0 Hz, 1H), 7.48–7.39 (m, 3H), 7.29–7.24 (m, 1H),
7.16 (t, J ¼ 8.0 Hz, 1H), 7.10 (d, J ¼ 8.8 Hz, 1H), 4.99 (d, J ¼ 7.6
Hz, 1H), 4.06 (d, J ¼ 5.6 Hz, 1H), 3.28–3.23 (m, 1H), 3.16–3.13
(m, 1H), 2.88–2.80 (m, 1H), 2.72–2.68 (m, 1H); 13C NMR (100
MHz, CDCl3): d ¼ 148.0, 147.8, 145.5, 144.7, 136.8, 130.6, 128.7,
128.4, 128.2, 127.3, 126.5, 126.2, 124.1, 123.7, 123.2, 120.0,
119.1, 111.5, 86.9, 71.0, 44.13, 29.6; m/z (ESI-MS) [M + H]+
calculated 406.1199 found 406.1191.()3q:(2S,3S,11bR)-2,3-Bis(2-bromophenyl)-
2,3,5,6,11,11bhexahydrooxazolo[30,20:1,2]pyrido[3,4-b]indole
Colorless solid; yield 74%; (Rf ¼ 0.30 in hexanes/EtOAc 80 : 20
v/v); MP 152–154 C; IR (KBr): 3340, 3014, 2914, 1659, 1657,
1622, 1110, 680, 710 cm1; 1H NMR (400 MHz, CDCl3): d ¼ 8.36
(s 1H), 7.89 (d, J¼ 7.6 Hz, 1H), 7.59 (d, J¼ 8 Hz, 1H), 7.47 (d, J¼
7.6 Hz, 1H), 7.43–7.37 (m, 3H), 7.26 (t, J ¼ 10.4 Hz, 2H), 7.18–
7.22 (m, 3H), 7.04 (t, J ¼ 8.0 Hz, 1H), 6.23 (s, 1H), 5.52 (d, J ¼ 7.2
Hz, 1H), 4.66 (d, J ¼ 7.2 Hz, 1H), 3.25–3.21 (m, 1H), 3.15–3.12
(m, 1H), 2.93–2.86 (m, 1H), 2.70–2.69 (m, 1H); 13C NMR (100
MHz, CDCl3): d ¼ 138.1, 132.8, 132.4, 131.4, 129.4, 129.2, 128.9,
127.8, 127.7, 125.2, 122.9, 122.6, 119.6, 119.1, 111.4, 110.5, 86.8,
85.5, 69.3, 44.3, 29.6, 18.0; m/z (ESI-MS) [M + H]+ calculated



































Colorless solid; yield 71%; (Rf ¼ 0.30 in hexanes/EtOAc 80 : 20
v/v); MP 168–170 C; IR (KBr): 3336, 3010, 2898, 1678, 1635,
1608, 1079 cm1; 1H NMR (400 MHz, CDCl3): d ¼ 8.14 (s, 1H),
8.01 (d, J ¼ 8.0 Hz, 1H), 7.91 (comp, 1H), 7.55 (comp, 1H), 7.48
(comp, 2H), 7.37 (comp, 2H), 7.29–7.23 (m, 4H), 7.18 (d, J ¼ 7.2
Hz, 5H), 6.75 (d, J¼ 6.4, 2H), 5.62 (d, J¼ 8.0 Hz, 1H), 4.52 (d, J¼
8.0 Hz, 1H), 3.18–3.13 (m, 1H), 3.06–3.03 (m, 1H), 2.78–2.70 (m,
1H), 2.6–2.58 (m, 1H); 13C NMR (100 MHz, CDCl3): d ¼ 146.1,
139.2, 136.2, 135.4, 134.1, 132.3, 132.1, 131.5, 131.3, 131.2,
130.0, 129.8, 129.7, 129.0, 128.97, 128.94, 128.8, 128.6, 128.4,
127.56, 127.52, 127.3, 127.2, 123.7, 121.8, 119.5, 115.3, 90.2,
75.1, 36.9, 21.1;m/z (ESI-MS) [M +H]+ calculated 443.2045 found
443.2051.
(Z)-3-Benzylidene-10,30-dihydro-3H-1,20-biisoindole
Colorless solid; yield 60%; (Rf ¼ 0.45 in hexanes/EtOAc 85 : 15
v/v); MP 98 C; IR (KBr): 3019, 2912, 1859, 1651, 1639, 1612
cm1; 1H NMR (400 MHz, CDCl3): d ¼ 8.23 (dd, J ¼ 4.8 Hz, 8.8
Hz, 2H), 7.65 (dd, J¼ 9.2 Hz, 16.4 Hz, 2H), 7.45–7.34 (comp, 9H),
6.58 (S, 1H), 5.38–5.25 (m, 4H); 13C NMR (100 MHz, CDCl3): d ¼
163.7, 148.6, 144.7, 136.4, 136.0, 132.1, 131.6, 128.6, 128.4,
127.1, 122.6, 122.0, 119.9, 111.99, 111.94, 29.6; m/z (ESI-MS)
[M + H]+ calculated 323.1470 found 323.1498.
(Z)-3-(4-Chlorobenzylidene)-10,30-dihydro-3H-1,20-biisoindole
Colorless solid; yield 65%; (Rf ¼ 0.60 in hexanes/EtOAc 8515
v/v); MP 104 C; IR (KBr): 3010, 2912, 890, 1678, 1649, 1612, 768
cm1; 1H NMR (400 MHz, CDCl3): d ¼ 8.22 (d, J ¼ 8.8 Hz, 2H),
7.79 (dd, J¼ 7.6 22.8 Hz, 2H), 7.45–7.34 (comp, 8H), 6.57 (s, 1H),
5.34–5.28 (m, 4H); 13C NMR (100 MHz, CDCl3): d¼ 163.7, 148.6,
144.7, 136.4, 136.0, 132.1, 131.6, 128.6, 128.4, 127.7, 127.1,
122.6, 122.0, 119.9, 111.99, 111.94, 29.6; m/z (ESI-MS) [M + H]+
calculated 357.1080 found 357.1088.
8-(4-Bromobenzyl)-3-(3-bromophenyl)-1,4-bis(4-
bromophenyl)-1H-pyrrolo[2,1-c][1,4]oxazine
Colorless solid; yield 65%; (Rf ¼ 0.60 in hexanes/EtOAc 8515
v/v); MP 215 C; IR (KBr): 3010, 2914, 1898, 1648, 1620, 1156,
748, 724, 688, 656 cm1; 1H NMR (400 MHz, CDCl3): d¼ 7.62 (d,
J¼ 8.0 Hz, 2H), 7.52 (d, J¼ 7.6 Hz, 2H), 7.38–7.36 (m, 2H), 7.31–
7.27 (m, 6H), 7.19–7.16 (m, 4H), 6.69 (d, J ¼ 8.0 Hz, 2H), 6.58 (d,
J ¼ 2.8, 1H), 3.71 (s, 2H); 13C NMR (100 MHz, CDCl3): d ¼ 137.9,
136.2, 135.4, 134.1, 133.1, 131.6, 130.4, 129.8, 129.6, 129.5,
129.4, 128.8, 128.2, 125.8, 121.1, 117.9, 112.4, 82.8, 35.2; m/z
(ESI-MS) [M + H]+ calculated 754.8316 found 754.8324.
8-(4-Chlorobenzyl)-3-(3-chlorophenyl)-1,4-bis(4-
chlorophenyl)-1Hpyrrolo[2,1-c][1,4]oxazine
Colorless solid; yield 63%; (Rf ¼ 0.60 in hexanes/EtOAc 8515
v/v); MP 210 C; IR (KBr): 3006, 2912, 2898, 1670, 1647, 1611,
1148, 828, 810, 784, 762 cm1; 1H NMR (400 MHz, CDCl3): d ¼
7.52 (d, J ¼ 8.4 Hz, 2H), 7.45 (d, J ¼ 8.8 Hz, 2H), 7.38–7.36 (m,
2H), 7.31–7.26 (m, 7H), 7.18–7.15 (m, 3H), 6.66 (d, J ¼ 6.4 Hz,This journal is © The Royal Society of Chemistry 20152H), 6.55 (d, J ¼ 2.8 Hz, 1H), 3.67 (s, 2H); 13C NMR (100 MHz,
CDCl3): d ¼ 136.0, 134.4, 133.2, 132.1, 130.549, 129.9, 129.0,
128.4, 128.2, 128.1, 128.0, 127.4, 127.0, 122.19, 122.18, 116.0,
111.2, 84.2, 33.2; m/z (ESI-MS) [M + H]+ calculated 578.0348
found 578.0368.
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